Amantadine

Amantadine

SCHEMBL7400188

C[C@@H](CS)C(=O)OC(CSc1cccc2ccccc12)C(=O)O.NC12CC3CC(CC(C3)C1)C2

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BM

The experimentally established mechanism targets of Amantadine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ACE P12821 1/20 0.36
ALDH1A1 P00352 3/20 0.33
LMNA P02545 3/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
KIF11 P52732 1/20 0.32
PPARG P37231 3/20 0.31
PPARA Q07869 3/20 0.31
EPHX2 P34913 1/20 0.30
XIAP P98170 1/20 0.30
SLC1A3 P43003 1/20 0.30
SLC1A2 P43004 1/20 0.30
SLC1A1 P43005 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amantadine SCHEMBL7400190 1.00 ACE (0.36) ACEALDH1A1LMNAMEN1HPGD
SCHEMBL7399896 0.88 LMNA (0.39) ACEALDH1A1LMNAMEN1HPGD
SCHEMBL7399898 0.88 LMNA (0.39) ACEALDH1A1LMNAMEN1HPGD
Amantadine SCHEMBL7394662 0.86 MTNR1A (0.34) ACEALDH1A1KMT2AEPHX2
Amantadine SCHEMBL7398747 0.86 MTNR1A (0.34) ACEALDH1A1KMT2AEPHX2
Amantadine SCHEMBL7394660 0.86 MTNR1A (0.34) ACEALDH1A1KMT2AEPHX2
SCHEMBL7400189 0.83 ALDH1A1 (0.35) ACEALDH1A1LMNAMEN1HPGD
Amantadine SCHEMBL7396700 0.81 PTGER1 (0.36) ALDH1A1KMT2A
Amantadine SCHEMBL7396703 0.81 PTGER1 (0.36) ALDH1A1KMT2A
Amantadine SCHEMBL7398627 0.81 ACE (0.46) ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0535042-B1 ANGIOTENSIS CONVERTING ENZYME INHIBITORS FISONS PLC (GB) 1995-03-29 EP disclosed
US-5348978-A Angiotensin converting enzyme inhibitors FISONS PLC (GB) 1994-09-20 US disclosed
EP-0535042-A1 ANGIOTENSIS CONVERTING ENZYME INHIBITORS. FISONS PLC (GB) 1993-04-07 EP disclosed
WO-1992000276-A2 ANGIOTENSIS CONVERTING ENZYME INHIBITORS FISONS PLC (GB) 1992-01-09 WO disclosed